L E T T E R T O T H E E D I T O R

Antimicrobial stewardship without infectious disease physician
To the Editor, I read with great interest the recent article reported by Murakami et al. 1 The authors conducted a before-and-after study to investigate the effects of an antimicrobial stewardship team (AST) without an infectious disease physician (IDP) on several outcomes in patients with candidemia. They concluded that non-IDP AST was associated with improved adherence to guidelines for managing candidemia, but not with improved 30-day mortality in patients with candidemia.
However, I think that important information on the prognosis of the five patients who received no antifungal treatment in the preintervention group is lacking in this article.
If all five patients died, it seems problematic that 30-day mortality in the intervention group was similar to that in the preintervention group, which included these five patients. Given that a past study reported improved mortality in patients with candidemia by AST intervention with an IDP, 4 the IDP's clinical judgment may be the most important aspect of improving the prognosis in patients with candidemia. Therefore, more discussion is needed regarding why the AST without an IDP did not improve mortality despite improving adherence to the guidelines for managing candidemia.
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